BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38698018)

  • 1. Assessing glycemic variability in critically ill patients: A prospective cohort study comparing insulin infusion therapy with insulin sliding scale.
    Almagthali A; Alsohimi S; Alkhalaf A; Al Sulaiman K; Aljuhani O
    Sci Rep; 2024 May; 14(1):10128. PubMed ID: 38698018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Basal Plus Versus Sliding Scale Insulin Therapy on Glucose Variability in Critically Ill Patients Without Preexisting Diabetes.
    Webster RE; Belfer JJ; Schmidt KJ
    Ann Pharmacother; 2024 Jun; 58(6):565-571. PubMed ID: 37700565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Hypoglycemia During Insulin Infusion Directed by Paper Protocol Versus Electronic Glycemic Management System in Critically Ill Patients at a Large Academic Medical Center.
    Rabinovich M; Grahl J; Durr E; Gayed R; Chester K; McFarland R; McLean B
    J Diabetes Sci Technol; 2018 Jan; 12(1):47-52. PubMed ID: 29251064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tight glucose control in critically ill children--a systematic review and meta-analysis.
    Srinivasan V; Agus MS
    Pediatr Diabetes; 2014 Mar; 15(2):75-83. PubMed ID: 24783254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
    Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
    Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive insulin therapy and mortality in critically ill patients.
    Treggiari MM; Karir V; Yanez ND; Weiss NS; Daniel S; Deem SA
    Crit Care; 2008; 12(1):R29. PubMed ID: 18312617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycemic gap upon mortality in critically ill patients with diabetes.
    Lou R; Jiang L; Zhu B
    J Diabetes Investig; 2021 Dec; 12(12):2212-2220. PubMed ID: 34075715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic variability and mortality in critically ill patients: the impact of diabetes.
    Krinsley JS
    J Diabetes Sci Technol; 2009 Nov; 3(6):1292-301. PubMed ID: 20144383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study.
    Galiatsatos P; Gibson BR; Rabiee A; Carlson O; Egan JM; Shannon RP; Andersen DK; Elahi D
    Crit Care Med; 2014 Mar; 42(3):638-45. PubMed ID: 24247476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective.
    Klonoff DC
    J Diabetes Sci Technol; 2011 May; 5(3):755-67. PubMed ID: 21722591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive versus conventional insulin therapy in critically ill neurologic patients.
    Green DM; O'Phelan KH; Bassin SL; Chang CW; Stern TS; Asai SM
    Neurocrit Care; 2010 Dec; 13(3):299-306. PubMed ID: 20697836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and rationale of Heart and Lung Failure - Pediatric INsulin Titration Trial (HALF-PINT): A randomized clinical trial of tight glycemic control in hyperglycemic critically ill children.
    Agus MS; Hirshberg E; Srinivasan V; Faustino EV; Luckett PM; Curley MA; Alexander J; Asaro LA; Coughlin-Wells K; Duva D; French J; Hasbani N; Sisko MT; Soto-Rivera CL; Steil G; Wypij D; Nadkarni VM
    Contemp Clin Trials; 2017 Feb; 53():178-187. PubMed ID: 28042054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients.
    Chant C; Wilson G; Friedrich JO
    Pharmacotherapy; 2005 Mar; 25(3):352-9. PubMed ID: 15843282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults.
    Kanji S; Singh A; Tierney M; Meggison H; McIntyre L; Hebert PC
    Intensive Care Med; 2004 May; 30(5):804-10. PubMed ID: 15127193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin Therapy in Hospitalized Patients.
    Pérez A; Ramos A; Carreras G
    Am J Ther; 2020; 27(1):e71-e78. PubMed ID: 31833876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a Paper-Based Dynamic Insulin Infusion Protocol on Glycemic Variability, Time in Target, and Hypoglycemic Risk: A Stepped Wedge Trial in Medical Intensive Care Unit Patients.
    Clergeau A; Parienti JJ; Reznik Y; Clergeau D; Seguin A; Valette X; du Cheyron D; Joubert M
    Diabetes Technol Ther; 2017 Feb; 19(2):115-123. PubMed ID: 28118045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia.
    Kim SH; Kim JY; Kim ES; Park IR; Ha EY; Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
    Ann Med; 2022 Dec; 54(1):2736-2743. PubMed ID: 36205625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor glycemic control is associated with increased mortality in critically ill trauma patients.
    Gale SC; Sicoutris C; Reilly PM; Schwab CW; Gracias VH
    Am Surg; 2007 May; 73(5):454-60. PubMed ID: 17520998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.
    Yamada T; Shojima N; Noma H; Yamauchi T; Kadowaki T
    Intensive Care Med; 2017 Jan; 43(1):1-15. PubMed ID: 27637719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.